𝔖 Bobbio Scriptorium

✦ LIBER ✦

Will patients with coronary artery disease benefit from inhibition of vascular angiotensin-converting enzyme? Rationale and design of the “Quo vadis” study

✍ Scribed by Y.M. Pinto; A.A. Voors; H. Buikema; J.G. Grandjean; T. Ebels; K.I. Lie; W.H. van Gilst

Book ID: 118326060
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 108 KB
Volume: 115
Category: Article
ISSN: 0021-9150
DOI: 10.1016/0021-9150(95)96459-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiotensin-converting enzyme inhibition

Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function: Ischemia Management with Accupril post–bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease

✍ Wiek H. van Gilst; J. Wayne Warnica; Richard Baillot; David Johnstone; Cristina- 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 115 KB

In women with symptoms of cardiac ischem

In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)

✍ Daniel F. Pauly; B. Delia Johnson; R. David Anderson; Eileen M. Handberg; Karen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 250 KB